Detalhe da pesquisa
1.
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.
J Hepatol
; 63(1): 102-13, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25660209
2.
Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
Oncotarget
; 7(19): 27108-21, 2016 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27027353